Microwave coagulation in addition to conventional transarterial chemoembolisation vs chemoembolisation
The review found no eligible studies for this question.
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
It is very uncertain whether microwave coagulation changes all‐cause mortality compared with radiofrequency ablation (very low certainty).
It is very uncertain whether transjugular intrahepatic portosystemic shunts changes all‐cause mortality compared with conventional treatment (very low certainty).
The review found no eligible studies for this question.
Double‐dose adenovirus‐thymidine kinase with ganciclovir… may leads to lower all‐cause mortality compared with liver transplantation (low certainty).
It is very uncertain whether adenovirus‐thymidine kinase with ganciclovir (ADV‐TK/GCV) plus liver… changes all‐cause mortality compared with liver transplantation (very low certainty).
Summary of findings table ‐ Antibiotics showed no clear difference in all‐cause mortality compared with placebo or no intervention (low certainty).
It is very uncertain whether summary of findings table ‐ Antibiotics changes all‐cause mortality compared with placebo or no intervention (very low certainty).
ePTFE‐covered stents may leads to lower all‐cause mortality compared with bare stents (low certainty).
It is very uncertain whether band ligation changes all‐cause mortality compared with sham or no intervention (very low certainty).
It is very uncertain whether vitamin D changes all‐cause mortality compared with placebo or no intervention (very low certainty).
It is very uncertain whether portosystemic shunts changes all‐cause mortality compared with endoscopic intervention with or without medical treatment (very low certainty).
It is very uncertain whether distal splenorenal shunt changes all‐cause mortality compared with endoscopic intervention (very low certainty).
It is very uncertain whether transjugular intrahepatic portosystemic shunt changes all‐cause mortality compared with endoscopic intervention with or without medical treatment (very low certainty).
It is very uncertain whether total shunt changes all‐cause mortality compared with endoscopic intervention (very low certainty).
It is very uncertain whether sclerotherapy changes all‐cause mortality compared with no intervention (very low certainty).
N‐acetylcysteine showed no clear difference in all‐cause mortality compared with placebo (low certainty).
N‐acetylcysteine showed no clear difference in all‐cause mortality compared with placebo (low certainty).
It is very uncertain whether plasma expanders changes all‐cause mortality compared with no plasma expanders (very low certainty).